Study Overview
Sex: All
Age: 18 Years / N/A
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex: All
Age: 18 Years / N/A
Terminated
Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors
Sex: All
Age: 18 Years / N/A
Sex: All
Age: 18 Years / N/A